Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

NCT03027245 · clinicaltrials.gov ↗

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Breast Cancer

Interventions

DRUG: Eribulin

Sponsor

Eisai GmbH